The convalescent plasma therapy global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Convalescent Plasma Therapy Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The convalescent plasma therapy market size has grown rapidly in recent years. It will grow from $0.05 billion in 2023 to $0.05 billion in 2024 at a compound annual growth rate (CAGR) of 11.8%. The growth in the historic period can be attributed to pandemics and infectious disease outbreaks, immunotherapy research, emergency use authorization (eua), patient availability, clinician and public awareness.
The convalescent plasma therapy market size is expected to see rapid growth in the next few years. It will grow to $0.08 billion in 2028 at a compound annual growth rate (CAGR) of 12.8%. The growth in the forecast period can be attributed to evolving pathogens, immunotherapies development, regulatory frameworks, global preparedness, public health initiatives. Major trends in the forecast period include standardized collection and processing, targeted plasma components, personalized treatment, telemedicine and remote monitoring, research into long-term effects.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/convalescent-plasma-therapy-global-market-report
Scope Of Convalescent Plasma Therapy Market
The Business Research Company’s reports encompass a wide range of information, including:
- Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
- Drivers: Examination of the key factors propelling market growth.
- Trends: Identification of emerging trends and patterns shaping the market landscape.
- Key Segments: Breakdown of the market into its primary segments and their respective performance.
- Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
- Macro Economic Factors: Assessment of broader economic elements impacting the market.
Convalescent Plasma Therapy Market Overview
Market Drivers –
Higher efficacy and safety evaluated during the trials conducted for CPT in COVID-19 patients can drive the market growth during the forecast period. Convalescent plasma transfusion has been of interest in the historical period for the treatment of other infectious disease outbreaks such as SARS-1, Middle East Respiratory Syndrome (MERS), and 2009 H1N1. In June 2020, results of a study conducted by the Houston Methodist hospital, which aimed at evaluating safety and efficacy of COVID-19 convalescent plasma therapy, stated that the convalescent plasma therapy is safe with no adverse events reported and is efficient with 76% recovery rate. In May 2020, a study published in the Journal of Medical Virology stated that with convalescent plasma therapy, the mortality rate may be reduced in critically ill patients, beneficial effects on clinical symptoms will be observed, and an increase in neutralizing antibody titers and disappearance of SARS-CoV-2 RNA will be observed. The safety and efficacy of the convalescent plasma therapy in COVID-19 patients will boost the global convalescent plasma therapy market growth.
Market Trends –
The development of antibody-based immunotherapy as a potential therapeutic intervention for COVID-19 shows opportunities for the convalescent plasma therapy market. Convalescent plasma therapy utilizes the antibodies produced against coronavirus by the donor to improve the immunity of the recipient. Companies are initiating trials, collaborating and investing for antibody-based COVID-19 therapy. In August 2023, Regeneron Pharmaceuticals Inc., a US-based biotechnology company, entered into a collaboration with the Biomedical Advanced Research and Development Authority (BARDA), to aid with the next-generation COVID-19 monoclonal antibody therapy’s clinical development, clinical manufacturing, and regulatory licensure processes for preventing SARS-CoV-2 infection. This collaboration is a part of Project NextGen, an effort by the U.S. Department of Health and Human Services (HHS) to create a pipeline of modern COVID-19 vaccines and therapies. In accordance with the project’s structure, Regeneron will independently develop and suggest an antibody candidate, which BARDA and Regeneron will then assess and select for additional research, manufacturing, and regulatory efforts. As convalescent plasma therapy utilizes antibodies, the focus over antibody-based COVID-19 therapy is expected to boost the market growth.
The convalescent plasma therapy market covered in this report is segmented –
1) By Antibody type: IgM, IgG, IgA
2) By Application: Prophylaxis, Treatment
3) By End-Users: Hospitals & Clinics, Laboratories & Research institutes
Get an inside scoop of the convalescent plasma therapy market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=3233&type=smp
Regional Insights –
North America was the largest region in the convalescent plasma therapy market in 2023. Western Europe was the second largest region in the convalescent plasma therapy market. The regions covered in the convalescent plasma therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Key Companies –
Major companies operating in the convalescent plasma therapy market include Bio Farma, Hilton Pharma Ltd., Biotest AG, BPL Ltd., LFB SA, Octapharma AG, CSL Behring LLC, Takeda Pharmaceutical Company Ltd., Orthosera Kft., ADMA Biologics Inc., GC Biopharma Corp, Grifols S.A, Sanquin Plasma Products B.V., America’s Blood Centers, Blood Centers of America Inc., Anthem Inc., Laboratory Corporation of America Holdings, Cerus Corporation, Emergent BioSolutions Inc., Kedrion Biopharma Inc., New York Blood Center, Blood Systems Inc., OneBlood Inc., Gulf Coast Regional Blood Center, Bloodworks Northwest, Blood Assurance Inc., New York Blood Center Inc., Honolulu Blood-Plasma Bank, Community Blood Center, LifeStream Blood Bank
Table of Contents
- Executive Summary
- Convalescent Plasma Therapy Market Report Structure
- Convalescent Plasma Therapy Market Trends And Strategies
- Convalescent Plasma Therapy Market – Macro Economic Scenario
- Convalescent Plasma Therapy Market Size And Growth
…..
- Convalescent Plasma Therapy Market Competitor Landscape And Company Profiles
- Key Mergers And Acquisitions
- Future Outlook and Potential Analysis
- Appendix
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
